Categories: Patient Advocate, Patient Engagement, Policy, Priority partners, Rare Disease, Strategy The Untold Value of Patient Insights
Categories: Compassionate Use, Expanded Access, Market Access, Patient Advocate, Pre-Approval Access, Pre-approval Drug Access, Report Expanded Access to Experimental Medicines – Where is Federal Legislation taking us?
Categories: Patient Advocate, Patient Centricity, Patient Engagement, Strategy Alternative Facts on Social Media: Implications for Patient Education
Categories: Compassionate Use, Expanded Access, Policy, Pre-Approval Access, R&D, Strategy Trial Innovations: Potential Impact on Access to Experimental Treatments
Categories: Compassionate Use, Expanded Access, Policy, Pre-Approval Access, R&D, Strategy Pre-Approval Access Program Value Proposition
Categories: Innovation, Patient Advocate, Patient Centricity, Patient Engagement, Patient Journey Mapping, R&D Unprecedented Excitement about Advances in Lung Cancer Research at 2017 ASCO
Categories: Patient Advocate, Policy Protecting Patients’ Access to Health Insurance: Perspective from The National Coalition for Cancer Survivorship (NCCS)
